Skip to main content

Table 1 Demographic parameters according to the M-CHARTS-detected metamorphopsia in patients with resolved central serous chorioretinopathy

From: Clinical parameters related to metamorphopsia outcome in patients with resolved central serous chorioretinopathy using M-CHARTS: retrospective cohort study

 

With metamorphopsia (n = 19)

Without metamorphopsia (n = 17)

P value

Age (years)

49.7 ± 8.7

52.1 ± 8.5

0.357

Sex, men : women (n)

14 : 5

16 : 1

0.182

Diagnosis, acute : chronic-recurrent (n)

3 : 16

11 : 6

0.003

Symptom duration (months)

10.5 ± 6.7

4.5 ± 4.0

0.003

Treatment

   

 Spontaneous resolution (n, %)

6, 31.6 %

7, 41.2 %

0.549

 Focal laser photocoagulation (n, %)

7, 36.8 %

3, 17.6 %

0.199

 Photodynamic therapy (n, %)

10, 52.6 %

8, 47.1 %

0.738